Regenxbio (RGNX) Gross Margin (2014 - 2025)
Regenxbio's (RGNX) quarterly Gross Margin came in at 78.16% in Q4 2025, up 795.0% year-on-year from 8.73% in Q4 2024, and down 3.2% quarter-over-quarter from 80.75% in Q3 2025.
Regenxbio (RGNX) Gross Margin (2014 - 2025) Analysis & Trends
Regenxbio's Gross Margin history runs 12 years deep, the most recent figure standing at 78.16% for Q4 2025.
- On a quarterly basis, Gross Margin rose 795.0% year-over-year to 78.16% in Q4 2025; TTM through Dec 2025 was 87.72%, a 2836.0% increase from a year earlier, with the FY2025 full-year figure at 87.01%, up 2729.0% from the prior year.
- Gross Margin retreated to 78.16% in Q4 2025 per RGNX's latest filing, from 80.75% in the prior quarter.
- Across five years, Gross Margin topped out at 96.05% in Q1 2025 and bottomed at 29.26% in Q1 2022.
- The 5-year median for Gross Margin is 59.78% (2022), against an average of 64.42%.
- Across the five-year window, Gross Margin plunged 4505 bps in 2022 and soared 4925 bps in 2023, its largest moves.
- Year by year, Gross Margin stood at 94.22% in 2021, then tumbled by 37 bps to 59.22% in 2022, then retreated by 17 bps to 49.41% in 2023, then surged by 42 bps to 70.22% in 2024, then rose by 11 bps to 78.16% in 2025.
- Per Business Quant, the three latest RGNX Gross Margin figures stand at 78.16% (Q4 2025), 80.75% (Q3 2025), and 75.61% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | 78.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 78.16% |
| Sep 30, 2025 | 80.75% |
| Jun 30, 2025 | 75.61% |
| Mar 31, 2025 | 96.05% |
| Dec 31, 2024 | 70.22% |
| Sep 30, 2024 | 48.81% |
| Jun 30, 2024 | 51.57% |
| Mar 31, 2024 | 72.09% |
| Dec 31, 2023 | 49.41% |
| Sep 30, 2023 | 57.16% |
| Jun 30, 2023 | 52.57% |
| Mar 31, 2023 | 78.51% |
| Dec 31, 2022 | 59.22% |
| Sep 30, 2022 | 50.61% |
| Jun 30, 2022 | 60.33% |
| Mar 31, 2022 | 29.26% |
| Dec 31, 2021 | 94.22% |
| Sep 30, 2021 | 54.16% |
| Jun 30, 2021 | 55.44% |
| Mar 31, 2021 | 74.31% |